Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | MITF | O75030 | 1/20 | 0.42 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | GSTP1 | P09211 | 7/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ACACB | O00763 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30689424 | 0.87 | TP53 (0.43) | TP53MITFNCOA3LMNAATM | |
| SCHEMBL30689423 | 0.86 | TP53 (0.41) | TP53MITFNCOA3LMNAATM | |
| SCHEMBL30689347 | 0.85 | IP6K1 (0.48) | TP53MITFNCOA3LMNAATM | |
| SCHEMBL31528007 | 0.82 | MITF (0.43) | TP53MITFNCOA3LMNAATM | |
| SCHEMBL30689449 | 0.82 | LMNA (0.44) | TP53MITFNCOA3LMNAATM | |
| SCHEMBL30689438 | 0.81 | LMNA (0.51) | TP53MITFNCOA3LMNAATM | |
| SCHEMBL31527827 | 0.79 | TP53 (0.46) | TP53MITFNCOA3LMNAATM | |
| SCHEMBL31527955 | 0.79 | LMNA (0.46) | TP53MITFNCOA3LMNAATM | |
| SCHEMBL30689303 | 0.79 | TP53 (0.42) | TP53MITFNCOA3LMNAATM | |
| SCHEMBL30689336 | 0.78 | LMNA (0.43) | TP53MITFNCOA3LMNAATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4543875-A1 | OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES | Sitryx Therapeutics Limited (GB) | 2025-04-30 | — | — | EP | disclosed |
| WO-2023247958-A1 | OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES | SITRYX THERAPEUTICS LIMITED (GB) | 2023-12-28 | — | — | WO | disclosed |